To acclimate to hypoxia, tumor cells develop defective apoptosis through HIF1-mediated variations in pro- and anti-apoptotic members of the Bcl-2 protein family, which represents a pivotal explanation for drug resistance [27]. The gene discussed is BCL2; the disease is neoplasm.